AllTranz, Inc. Product PIPELINE for Pain Modulation:
The AllTranz pipeline of products will target pain modulation, as well as substitution treatment for opiate addiction and alcohol abuse.
The AllTranz technology addresses not only pharmacological limitations but the abuse potential and need for
constant monitoring which confound the utility of current opioids.
| Drug | Patent Status |
Chemical Entity Screening |
Formulation | Preclinical Toxicology |
Clinical Trials |
Potential Registration |
| ALL00099 | Pending patents | 2007-2008 | 2008/2009 | 2009 | 2010-2014 | 2015 |
| Cannabinoid 2 | Pending patents | 2007-2008 | 2008/2009 | 2009-2010 | 2010-2014 | 2015 |
| Narcotic Analgesic | Pending patents/issued claims | 2007-2008 | 2008/2009 | 2009-2010 | 2010-2014 | 2015 |